US FDA authorizes Moderna, Pfizer updated COVID-19 boosters for 6 months old children

Published: Updated:
Enable Read mode
100% Font Size

The US Food and Drug Administration on Thursday authorized updated COVID-19 booster shots from Moderna and Pfizer and its partner BioNTech for children as young as 6 months of age.

The amended authorizations allow use of Moderna’s bivalent shot in children 6 months through 5 years of age, while the Pfizer/BioNTech vaccine can be given to those aged 6 months through 4 years.

Pfizer’s shot can be administered as the third shot for those eligible and have not completed their primary vaccination series, the agency added.

For the latest headlines, follow our Google News channel online or via the app.

Read more:

Transport strikes push Christmas party cancellations near COVID-19 levels

China announces nationwide loosening of COVID-19 restrictions after protests

New Zealand authorities take temporary custody of ill baby from anti-vax parents

Top Content Trending